Showing results (1-10 of 21) with videos related to
Sort By:
Pageof 3
The Journal of Biological Chemistry|March 12, 2005
Degradation of trafficking-defective long QT syndrome type II mutant channels by the ubiquitin-proteasome pathwayQiuming Gong, David R Keeney, Maurizio Molinari, et al.Water Environment Research : a Research Publication of the Water Environment Federation|August 30, 2008
Microbial fouling of a reverse osmosis municipal water treatment systemSteven J Wright, Jeremy D Semrau, David R KeeneyEnvironmental Health Perspectives|August 1, 1977
Occurrence and distribution of arsenic in soils and plantsL M Walsh, M E Sumner, D R KeeneyJournal of Molecular and Cellular Cardiology|December 2, 2004
Defective assembly and trafficking of mutant HERG channels with C-terminal truncations in long QT syndromeQiuming Gong, David R Keeney, Jeffrey C Robinson, et al.Journal of Proteomics|September 17, 2009
The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics arrayRachel Ostroff, Trudi Foreman, Tracy R Keeney, et al.Journal of Biomedical Materials Research. Part B, Applied Biomaterials|October 12, 2022
Mechanical alterations of electrospun poly(ϵ-caprolactone) in response to convective thermobondingAli Behrangzade, Hannah R Keeney, Katarina M Martinet, et al.Applied and Environmental Microbiology|October 3, 2006
Mixed pollutant degradation by Methylosinus trichosporium OB3b expressing either soluble or particulate methane monooxygenase: can the tortoise beat the hare?Sung-Woo Lee, David R Keeney, Dong-Hee Lim, et al.Antimicrobial Agents and Chemotherapy|March 1, 1982
Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humansO L Laskin, J A Longstreth, R Saral, et al.Proteomics. Clinical Applications|October 3, 2012
Apolipoprotein A-I: insights from redox proteomics for its role in neurodegenerationJeriel T R Keeney, Aaron M Swomley, Sarah Förster, et al.Sexually Transmitted Diseases|January 1, 1988
Chronic suppression for six months compared with intermittent lesional therapy of recurrent genital herpes using oral acyclovir: effects on lesions and nonlesional prodromesS L Sacks, R Fox, P Levendusky, et al.Pageof 3